In This Article:
Key Points
-
Target has growth opportunities, particularly in its digital sales business, and boasts an impressive dividend profile.
-
Bristol Myers Squibb can overcome recent and future patent cliffs thanks to newer approvals.
Stocks experienced significant volatility…